KGFHY Stock UPDATES Kingfisher New ADR (KGFHY) 10.4300 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kingfisher New ADR (KGFHY) 10.4300 $KGFHY

Office Depot is Now Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 3:52PM CDT
On Mar 18, 2014, Zacks Investment Research downgraded Office Depot to a Zacks Rank #5 (Strong Sell). The shares of this office supplies retailer have tumbled 14.4% year-to-date.

Falling Earnings Estimates Signal Weakness Ahead for Office Depot (ODP) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:38AM CDT
Office Depot (ODP) sees falling earnings estimates and significant price decline, as the stock has dropped nearly 11.9% over the past month.

Falling Earnings Estimates Signal Weakness Ahead for Staples (SPLS) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:54AM CDT
Staples has witnessed a significant price decline in the past four weeks. The reason is negative trend in earnings estimate revisions. The stock also has seen some pretty dismal trading lately.

Staples Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:53PM CDT
Staples (SPLS) missed the Zacks Consensus Estimate in the trailing four quarters by an average of 8.2%.

Why You Need to Pay Attention to Barnes & Noble (BKS) Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 8:00AM CDT
Barnes & Noble has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.

Office Depot (ODP) Falls: Stock Goes Down 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:44AM CST
Office Depot's shares fell about 6% on the day. This continues the recent downtrend for ODP, as the stock is now down nearly 10% since Feb 24.

PetSmart Q4 Earnings Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 9:16AM CST
PetSmart posted fourth-quarter earnings of $1.28 per share, which easily surpassed the Zacks Consensus Estimate of $1.21 per share and rose 3.2% year over year.

Barnes & Noble Up to Strong Buy on Solid Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 4:47PM CST
On Mar 1, 2014, Zacks Investment Research upgraded Barnes & Noble to a Zacks Rank #1 (Strong Buy) on solid third-quarter fiscal 2014 results.

Should You Get Rid of Steiner (STNR) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:49AM CST
Steiner has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. It could be time to get rid of the security before more losses hit your portfolio.

Office Depot Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 1:45PM CST
On Mar 1, 2014, Zacks Investment Research downgraded Office Depot to a Zacks Rank #5 (Strong Sell).

Falling Earnings Estimates Signal Weakness Ahead for Big 5 Sporting Goods (BGFV) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 7:39AM CST
Big 5 Sporting Goods has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.

Office Depot (ODP) in Focus: Stock Tumbles 8.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:36AM CST
The shares of Office Depot fell nearly 9% on the day. This reverses the recent trend for ODP, as the stock is now up nearly 12% since Feb 3. This supplier of office products and services has seen a flat track record when it comes to current year estimate revisions.

Tractor Supply Enhances Share Buyback Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 6:15PM CST
Tractor Supply's Board of Directors authorized the company to buy back additional shares worth $1 billion, taking the total authorization to $2 billion.

Barnes & Noble Up on Talks of G Asset Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 1:00PM CST
Barnes & Noble saw its shares rise 5% after private investment firm, G Asset Management, reportedly offered to buy a majority stake in the company.

Steiner Leisure (STNR) in Focus: Stock Plunged 11.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:47AM CST
The shares of Steiner Leisure fell over 11% on the day. This reverses the recent trend for STNR, as the stock is now up nearly 6% since Feb 5. This provider of spa services and personal care products has seen a flat track record when it comes to current year estimate revisions.

1-800-Flowers.com (FLWS) Crumbles: Stock Falls by 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:00AM CST
1-800-Flowers.com Inc. (FLWS) saw a big move last session, reversing the recent trend for FLWS, as the stock is now up more than 5% since Jan 29.

Ulta Salon (ULTA) in Focus: Stock Surges 17.3% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 16, 7:00AM CDT
Ulta Salon, Cosmetics & Fragrance, Inc. saw its shares surge by more than 17% on the day.

Penny Stocks Trend Analysis Reports On: (OTCQB: TTNP), (OTCQX: KGFHY)
ACCESSWIRE-TNW - Tue Apr 23, 1:31PM CDT
New York (April 23rd, 2013) - Titan Pharmaceuticals Inc. (OTCQB: TTNP) opened at $1.94 and oscillated in the range of $1.84 and $1.99 in the latest trading session. It is at $1.87, down 4.10 percent from its previous close of $1.95. Titan Pharmaceuticals is currently trading below its short term SMA and long term SMA of $1.92 and $1.93 respectively. Titan Pharmaceuticals stock is up 72.07 percent on YTD basis while its 52 weeks gain stands at 176.81 percent.

Market Maker Surveillance Report. PRKR, SCON, SWY, ADXS, KGFHY, BBRY, Highest Net Buy Volume With Lowest Price Friction For Thursday, February 21st 2013
M2 - Fri Feb 22, 2:36AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4014 companies with "abnormal" market making, 1704 companies with positive Friction Factors and 3708 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Thursday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Parkervision Inc (NASDAQ RKR), Superconductor Technologies Inc (NASDAQ:SCON), Safeway Inc (NYSE:SWY), Advaxis Inc (OTC:ADXS), Kingfisher PLC (OTC:KGFHY), (NASDAQ:BBRY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 7

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 66

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 26

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US: A Decade of Impressive Stock Growth Revealed

Updated Category News Views 142

T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...

Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report

Updated Category News Views 67

TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...

Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results

Updated Category News Views 179

C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...

Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech

Updated Category News Views 172

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges

Updated Category News Views 105

Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...

Continue Reading